Um artigo recente na eBioMedicine, parte do The Lancet Discovery Science, de Nicholas Ashton e Henrik Zetterberg, analisa os 10 anos de história dos testes de biomarcadores sanguíneos para a doença de Alzheimer e a transformação revolucionária do campo. Graças a tecnologias inovadoras como a Simoa®, biomarcadores sanguíneos como p-tau217, Aβ42/Aβ40 e NfL estão mudando o jogo em pesquisa, diagnóstico e monitoramento.
Destaques
New Cytokine Publication Brief
This new publication brief explores the power of Simoa® technology in immuno-oncology, featuring its impact on biomarker discovery and monitoring for improved cancer treatment outcomes.
New BD-Tau App Note
Discover how Simoa® assays enable ultra-sensitive detection of BD-Tau, a key plasma biomarker for AD and brain injury. Learn how BD-Tau enhances diagnosis and outcome prediction in this app note.
Introducing Nova Beads™
Engineered for consistency, scalability, and unmatched reliability, Nova Beads™ provide the perfect foundation for many research and manufacturing applications.
#QReview announcement
We've officially launched our integration with Bioz! You can now visit our website and view all publications related to Quanterix and Simoa® directly from our publications tab.
Upcoming Webinar
Join Quanterix experts to discover how to streamline performance study submissions, meet regulatory requirements, and fast-track approvals. Whether you're starting your IVDR journey or enhancing ongoing studies, this session will set you up for success.
Estamos aqui para ajudar!
Agende sua reunião hoje mesmo e descubra como a tecnologia Simoa está revolucionando a pesquisa. Seja você também um protagonista dessa transformação!
A Lab Research Brasil é distribuidora exclusiva da Quanterix.
📲 WhatsApp: +55 11 3991-9033 📧 E-mail: info@labresearch.com.br